DMD patients have higher CCN2/CTGF protein levels in skeletal muscle than control individuals, and the severity of the disease shows a direct correlation with CCN2/CTGF expression levels [48]. This evidence concerns the gene CCN2 and Duchenne muscular dystrophy.